Siplizumab combination therapy with belatacept or abatacept broadly inhibits human T cell alloreactivity in vitro
- Resource Type
- Short Communication
- Source
- In
American Journal of Transplantation October 2023 23(10):1603-1611 - Subject
- Language
- ISSN
- 1600-6135